GlycoNex Incorporation (4168.TWO)
TWD 19.4
(-9.98%)
TWD 19.4
(-9.98%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -148.56 Million TWD | -204.34% |
| 2022 | 142.39 Million TWD | 214.68% |
| 2021 | -124.16 Million TWD | 18.23% |
| 2020 | -151.84 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -116.09 Million TWD | 21.82% |
| 2024 Q1 | -148.5 Million TWD | 0.04% |
| 2023 FY | -148.56 Million TWD | -204.34% |
| 2023 Q2 | -117.58 Million TWD | -185.61% |
| 2023 Q1 | 137.35 Million TWD | 196.46% |
| 2023 Q3 | -108.49 Million TWD | 7.73% |
| 2023 Q4 | -148.56 Million TWD | -36.93% |
| 2022 Q4 | -142.39 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -92.834% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 43.761% |
| Level Biotechnology Inc. | -453.9 Million TWD | 67.269% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -23.221% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 24.354% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 129.722% |
| VBI | -25.31 Million TWD | -486.85% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 468.964% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 207.661% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 43.421% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 585.862% |
| Visgeneer Inc. | 31.28 Million TWD | 574.898% |
| Mycenax Biotech Inc. | 207 Million TWD | 171.768% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 78.171% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -10.663% |
| Neith Corporation | -150.31 Million TWD | 1.16% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 123.903% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -157.669% |
| Enimmune corporation | -314.15 Million TWD | 52.71% |
| TaiRx, Inc. | -147.86 Million TWD | -0.472% |
| CHO Pharma, Inc. | -203.79 Million TWD | 27.099% |
| EirGenix Inc. | -4.58 Billion TWD | 96.762% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -75.273% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 222.914% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 95.384% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 53.195% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -649.846% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 567.06% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 392.714% |
| RBC Bioscience Corporation | 422.18 Million TWD | 135.19% |
| BiOptic Inc. | 12.59 Million TWD | 1279.852% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 84.269% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -46.392% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 10.055% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 147.183% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -130.977% |
| NaviFUS Corp. | -123.12 Million TWD | -20.66% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 300.628% |
| Sinew Pharma Inc. | -160.34 Million TWD | 7.345% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 38.582% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 55.964% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 63.996% |
| AP Biosciences Inc | -196.52 Million TWD | 24.404% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 121.571% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -1199.003% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 82.094% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 110.946% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 64.19% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 29.03% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -3.27% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 55.054% |
| TCI GENE Inc. | -689.25 Million TWD | 78.445% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -24.911% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 88.652% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 825.319% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -45.84% |
| PharmaEngine, Inc. | -860.8 Million TWD | 82.741% |
| Savior Lifetec Corporation | -812.54 Million TWD | 81.716% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 50.472% |
| OBI Pharma, Inc. | -398.22 Million TWD | 62.693% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 59.343% |
| Acepodia, Inc. | -6.02 Billion TWD | 97.532% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 95.633% |